How to differentiate Coccidioidomycosis (Cocci) from Tuberculosis (TB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Coccidioidomycosis vs. Tuberculosis

When differentiating coccidioidomycosis from tuberculosis (TB), it's crucial to consider various factors, including clinical presentation, epidemiological history, and diagnostic test results. Here's a structured approach to the differential diagnosis:

  • Single Most Likely Diagnosis:

    • Coccidioidomycosis: This is likely if the patient has recently traveled to or resides in the southwestern United States, especially Arizona or California, and presents with symptoms such as pneumonia, fever, and fatigue, following exposure to soil or dust.
    • Tuberculosis: If the patient has a history of exposure to TB, has recently traveled to or immigrated from a high-prevalence country, and presents with chronic cough, weight loss, and night sweats.
  • Other Likely Diagnoses:

    • Histoplasmosis: Similar to coccidioidomycosis, histoplasmosis is a fungal infection that can present with respiratory symptoms and is more common in certain regions, such as the Ohio and Mississippi River Valleys.
    • Blastomycosis: Another fungal infection that can mimic TB or coccidioidomycosis, especially in patients with exposure to soil or water in endemic areas like the Midwestern United States.
    • Sarcoidosis: An autoimmune disease that can cause lung symptoms similar to TB or fungal infections and should be considered in patients with a compatible clinical presentation and no clear infectious cause.
  • Do Not Miss Diagnoses:

    • Malignancy (e.g., lung cancer): Can present with similar symptoms to TB or fungal infections, such as cough, weight loss, and fatigue. It's critical to rule out malignancy, especially in patients with risk factors.
    • Pneumocystis jirovecii pneumonia (PCP): Especially in immunocompromised patients, PCP can present with severe respiratory symptoms and requires prompt treatment.
    • Cryptococcosis: A fungal infection that can cause lung disease and meningitis, particularly in immunocompromised individuals, and has a high mortality rate if not treated.
  • Rare Diagnoses:

    • Paracoccidioidomycosis: A fungal infection more common in Latin America, which can cause lung and skin symptoms.
    • Sporotrichosis: Typically a skin infection caused by a fungus, but can rarely cause lung disease, especially in immunocompromised patients.
    • Aspergillosis: While more commonly associated with allergic reactions or localized infections, invasive aspergillosis can cause severe lung disease in immunocompromised individuals.

Each of these diagnoses requires careful consideration of the patient's clinical presentation, travel and exposure history, and laboratory findings to ensure accurate diagnosis and appropriate treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.